Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale.
about
Epidemiology and control of human gastrointestinal parasites in childrenEndovascular Recanalization Therapy in Acute Ischemic Stroke: Updated Meta-analysis of Randomized Controlled TrialsStroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices.Burden of disease in adults admitted to hospital in a rural region of coastal Kenya: an analysis of data from linked clinical and demographic surveillance systemsStroke Treatment Academic Industry Roundtable Recommendations for Individual Data Pooling Analyses in StrokeTranslation of evidence-based Assistive Technologies into stroke rehabilitation: users' perceptions of the barriers and opportunities.Comparison of 3-Month Stroke Disability and Quality of Life across Modified Rankin Scale Categories.Years of optimum health lost due to complications after acute ischemic stroke: disability-adjusted life-years analysisGraphic reanalysis of the two NINDS-tPA trials confirms substantial treatment benefitBurden of disease resulting from chronic mountain sickness among young Chinese male immigrants in TibetAssistive technologies after stroke: self-management or fending for yourself? A focus group study.Weighting components of composite end points in clinical trials: an approach using disability-adjusted life-yearsBurden of ischemic stroke in Korea: analysis of disability-adjusted life years lost.Disability-adjusted life years analysis: implications for stroke research.Review of disability weight studies: comparison of methodological choices and valuesThe Missing Medians: Exclusion of Ordinal Data from Meta-Analyses.A Novel Dietary Assessment Method to Measure a Healthy and Sustainable Diet Using the Mobile Food Record: Protocol and Methodology.Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin ScaleEffects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 TrialsA Modelling Approach to Estimate the Impact of Sodium Reduction in Soups on Cardiovascular Health in the Netherlands.Early decompressive craniectomy for malignant cerebral infarction: Meta-analysis and clinical decision algorithmOptimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices.Early Versus Late Assessment of Stroke Outcome.Factor associated with experience of modern contraceptive use before pregnancy among women who gave birth in Kersa HDSS, Ethiopia.Perfusion computed tomography in patients with stroke thrombolysis.The disability adjusted life years due to stroke in South Africa in 2008.New stent retriever devices.Efficacy of adhesive taping as an adjunt to physical rehabilitation to influence outcomes post-stroke: a systematic review.Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials.Validation of the Spanish version of the Trunk Impairment Scale Version 2.0 (TIS 2.0) to assess dynamic sitting balance and coordination in post-stroke adult patients.The relationship between communication activities of daily living and quality of life among the elderly suffering from stroke.Outcomes of General Anesthesia and Conscious Sedation in Endovascular Treatment for Stroke.Mechanical recanalization in ischemic anterior circulation stroke within an 8-hour time window: a real-world experience.Disease burden of stroke in Kolkata, India: derivation of disability-adjusted life years by a direct method.Baicalin attenuates focal cerebral ischemic reperfusion injury by inhibition of protease-activated receptor-1 and apoptosis.Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review.Penumbral salvage and thrombolysis outcome: a drop of brain, a week of life.Alleviation of glutamate mediated neuronal insult by piroxicam in rodent model of focal cerebral ischemia: a possible mechanism of GABA agonism.Safety and efficacy of remote ischemic conditioning in pediatric moyamoya disease patients treated with revascularization therapy
P2860
Q24601973-6470F942-8978-4B88-8FD4-F7B4FBFBDA1CQ26781917-FD499DFC-7C6C-4E38-BB4A-862BC878AD4CQ30689276-E73712D8-1B0A-4315-A065-7FC965D9CF7BQ30811807-004C8381-FB3B-466A-99FF-B9438B610C8BQ31114160-30B85488-DF8A-41A8-BF31-9BDD7121A6E4Q33556726-0F95F6A6-BC12-4792-A2E3-29BAE84D88E5Q33781992-1976D32F-1E03-448A-B15C-E12AEB36B108Q34118097-4349BBE3-153D-4043-98DE-21B8613E4439Q34170539-844CCED1-D4BB-4608-9327-4FCF9FE1ECCCQ34294401-BC9E2D8C-B8A1-4343-8369-E539EF9A62D1Q34966814-86C9ACEE-E668-47F6-AFBA-8D3010D0C02DQ35029327-4A77A892-6BE1-4D6D-9FFE-8C47AFE605BBQ35091676-E079018A-81D5-4BE9-BFD2-A8629547244AQ35539636-D3F5DE86-4A60-421C-8DF4-68A052EFF69FQ35653593-255F5F31-24D1-45C0-B891-C754768423ECQ35876455-724C7FE3-D26A-479A-A050-CC1272321484Q35894992-934B78FC-1BBC-42EA-B695-488E69E0873AQ35901029-F0D54299-9B59-4A5A-93FF-190A589B9605Q36099907-69A6DE36-721D-48B2-B099-DBD8886EC18AQ36102169-FC57F38F-25F8-4B12-A065-E401FBADCFF5Q36193628-1A2A93AD-40AF-4C38-A801-1CFEEF2AF2B7Q36294488-52D0D3BA-B521-4E59-B6C4-06AEC1F19BA2Q37078586-0DCA5980-B5F0-4C3D-B22B-86D651DB8028Q37118294-BF9148A1-D7F9-4C8F-A4EA-FBD67B1E1CA5Q37739884-B4196B89-17C6-4233-9772-86BBF7EACD4CQ38072166-496598AD-E662-47EE-827A-7CDF098874D5Q38102594-893FC633-4F74-4410-8482-2BD6C01D79F8Q38380002-52F1F4CB-D1A6-4501-A25B-FD38A7DC571AQ38669629-B7CECE51-781C-481B-8034-6FE658FCB7F9Q38902453-FF1A6685-9415-4C3B-B07C-C66D883B77C7Q39676278-DCF20518-2C87-48D3-9D36-DAFE64938CBBQ40654511-227E1124-ECBA-48D0-9C2C-86243796E104Q43232072-C489EA98-7F66-4179-A4F4-294F6322682CQ44779499-37EB8DB5-265E-4ADD-9E52-FB72A279391FQ45904111-96B704E2-7EE8-4D2D-81A3-D3DD6F7BF84DQ47190259-22CACD15-D95A-4000-BBDC-6243F75CC53FQ47854993-00B88BCF-8D48-4D8A-B1C4-63689B725F80Q48235898-D302EED8-3F69-4D5A-BE7A-9D7C026EF2B0Q48493656-553BD26A-97A9-4344-95FF-04D2621D937BQ57152096-4EC24734-7EDE-4227-9AF6-1CB2613F7803
P2860
Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantifying the value of strok ...... of the modified Rankin Scale.
@en
Quantifying the value of strok ...... of the modified Rankin Scale.
@nl
type
label
Quantifying the value of strok ...... of the modified Rankin Scale.
@en
Quantifying the value of strok ...... of the modified Rankin Scale.
@nl
prefLabel
Quantifying the value of strok ...... of the modified Rankin Scale.
@en
Quantifying the value of strok ...... of the modified Rankin Scale.
@nl
P2860
P1433
P1476
Quantifying the value of strok ...... of the modified Rankin Scale.
@en
P2093
Jeffrey L Saver
Keun-Sik Hong
P2860
P304
P356
10.1161/STROKEAHA.109.561365
P407
P577
2009-10-01T00:00:00Z